This brand name is authorized in Nigeria.
The drug ANDRALOCAIN + AD contains a combination of these active pharmaceutical ingredients (APIs):
1
|
UNII
98PI200987 - LIDOCAINE
|
|
Lidocaine, like other local anaesthetics, causes a reversible blockade of impulse propagation along nerve fibres by preventing the inward movement of sodium ions through the nerve membrane. Local anaesthetics of the amide-type are thought to act within the sodium channels of the nerve membrane. |
|
2
|
UNII
YKH834O4BH - EPINEPHRINE
|
|
Epinephrine is a direct acting sympathomimetic agent, which exerts effects on both α and β adrenoceptors. It has more pronounced effects on β than on α adrenoceptors, although α effects prevail at high doses. The effects of adrenaline include increased rate and force of cardiac contraction, cutaneous vasoconstriction and broncho-dilatation. |
|
This drug has been approved in Nigeria as follows:
| Identifier | Form | Presentation | Description | Approval |
|---|---|---|---|---|
| A4-7806 | Injection | ANDRALOCAIN + AD INJECTION INJ 20 mg 25VIALS X 30ML | 7 ANDRALOCAIN + AD INJECTION ANDRALOCAIN + AD INJECTION LIDOCAINE HYDROCHLORIDE BP 20MG, ADRENALINE P 0.0125MG POM INJECTION 25VIALS X 30ML LOCAL ANAESTHETIC AMAKING PHARMACEUTICALS NIG. LTD 25, OTUNBA, GBADAMOSI, ESADO STREET, OLADI APAPA LAGOS STATE. PHARMAX INDIA PVT. LIMITED 9, KURLA INDUSTRIAL ESTATE, PALKAR LBS, MARG GHATKOPAR (W), MUMBAI-400086, INDIA. GMP- CLEARANCE ;LR; FEES-PAID;NP:NA A4-7806 | 23/02/2023 |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC Group | Classification | |
|---|---|---|
| N01BB52 | Lidocaine, combinations | N Nervous system → N01 Anesthetics → N01B Anesthetics, local → N01BB Amides |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| NG | Registered Drug Product Database | A4-7806 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.